9:30 AM ET
8-K
Capital Raise
MapLight Therapeutics Capital Raise
MapLight Therapeutics entered into a sales agreement with Leerink Partners to establish an at-the-market (ATM) offering program. The company may sell up to $100 million of its common stock from time to time, with Leerink acting as the sales agent for a commission of up to 3.0%.
- Counterparty
- Leerink Partners LLC